No differences in Tbx21 or IFN-γ levels in ALS patients' leukocytes were observed compared with controls (Supporting Information Fig 3A and C) and there were no correlations with disease progression rates (Supporting Information Fig 3B and D). The gene discussed is TBX21; the disease is amyotrophic lateral sclerosis.